Date (날짜): July 18, 2024
Time (시간): 10:00am - 6:00pm
Place: Courtyard Seoul Pangyo
CDD의 창립 20주년을 기념하는 특별한 해를 맞이하여, 한국의 기술 및 과학 커뮤니티를 위한 Collaborative Drug Discovery 커뮤니티 미팅에 여러분을 초대합니다.
올해에는 다음과 같은 저명한 연사분들이 참여하십니다.
올해에는 다음과 같은 저명한 연사분들이 참여하십니다.
- 한우석 부대표님, 사이러스 테라퓨틱스
- 박성진 연구소장님, 아밀로이드 솔루션
- 김원일 연구소장님, 진원생명과학
- 백태곤 대표님, 아름 테라퓨틱스
- 김한조 연구소장님, 네오켄바이오
- Charlie Weatherall, CDD
- Dr. Roland Saito, CDD
- Emilia Hietala, CDD
CDD Vault의 중요한 업데이트를 확인하고 업계 동향에 대해 파악할 수 있는 맞춤형 교육을 제공합니다.
또한, 흥미로운 기조연설을 듣고 업계 전문가들과 네트워크하며 새로운 전략을 논의할 수 있는 기회를 제공합니다.
아래에서 Agenda를 확인하시기 부탁 드립니다.
Collaborative Drug Discovery Community Meeting brings the Korean technology and scientific communities together. This year is special as we are celebrating CDD's 20 years of excellence.
This year we have a stellar list of speakers including,
- Dr. WooSeok Han, from Cyrus Therapeutics
- Dr. Seong Jin Park from Amyloid Solutions,
- Dr. Wonil Kim from GeneOne Life Science,
- Dr. Mark Taegon Baik from ARUM Therapeutics,
- Dr. Hanjo Kim from Neocannbio
- Charlie Weatherall, CDD
- Dr. Roland Saito, CDD
- Emilia Hietala, CDD
There will be a round table discussion on the impact of AI/ML on the Korean Biotech Industry chaired by Dr. Hanjo Kim, Neocann Bio.
We invite you to join us to discover important CDD Vault updates, learn about industry trends, discuss strategies on best practices with peers, get personalized training, listen to engaging keynotes, and network with industry experts.
Agenda
- 10:00-10:20: Registration and networking.
- 10:20-10:30: Welcome.
- 10:30-11:00: Discovery of CYRS1542, a potent and orally bioavailable GSPT1 molecular glue degrader for the treatment of patients with AML and SCLC. Dr. WooSeok Han, CSO and Executive VicePresident, Cyrus Therapeutics.
- 11:00-11:30: Simplifying research data management with CDD Vault. Charlie Weatherall, PhD., Director of Customer Engagement, CDD.
- 11:30-11:50: New easy-to-use Machine Learning tools in CDD Vault. Roland Saito, Sr. Applications Scientist, CDD.
- 11:50-12:20: Targeting amyloid aggregates, Dr. Seong Jin Park, Head of Amyloid and Medicinal Chemistry groups, Amyloid Solutions.
- 12:20- 13:30: Lunch and Networking.
- 13:30-14:00: Pre-clinical evaluation of small molecule CHK2 inhibitor, ART-446. Mark Taegon Baik, CEO and Founder, Arum Therapeutics
- 14:00-14:30: Exciting new Protocols and Curve Fitting functionalities in CDD Vault. Emilia Hietala, Applications Scientist, CDD.
- 14:30-15:00: mRNA-based therapeutic applications in addition to prophylactic vaccines. Dr. Wonil Kim, Director of R&D Center, GeneOne Life Science Inc.
- 15:00-15:20: Break and Networking.
- 15:20-16:20: The impact of AI in drug discovery: present and future. Panel discussion.
- Dr. Hanjo Kim, Research Director, Neocannbio. Chair.
-
Dr Yuyoung Song, Principal AI Scientist - Standigm
- Dr Jae-Mun Choi, CEO Calici Therapeutics and Adjunct Professor at Korea University
- Dr Art Cho, CEO inCerebro and Professor at Korea University
- 16:20-16:40: Charting the Course: CDD Vault Roadmap. Kellan Gregory, Head of Product Excellence, CDD.
- 16:40-18:30: Food, Drinks and Networking
This FREE event includes lunch, refreshment and networking with our vibrant community.
Looking forward to welcoming you at the Community Meeting.